Impact of baseline steroids on efficacy of programmed cell death-1 (PD-1) and programmed death-ligand 1 (PD-L1) blockade in patients with advanced non-small cell lung cancer

Transl Lung Cancer Res. 2019 Dec;8(Suppl 4):S364-S368. doi: 10.21037/tlcr.2019.06.06.

Authors

Maria Jove^{1

2}, Noelia Vilariño^{1

2}, Ernest Nadal^{1

2}

Affiliations

¹ Department of Medical Oncology, Catalan Institute of Oncology, L'Hospitalet (Barcelona), Spain.
² Research in Solid Tumors (CReST) Group, Oncobell Program, Bellvitge Biomedical Research Institute, L'Hospitalet (Barcelona), Spain.

No abstract available

Publication types

Editorial
Comment